Form 4: Heron Therapeutics Executive Exercises Stock Options, Increases Holdings

William P. Forbes, EVP and Chief Development Officer at Heron Therapeutics, exercised stock options and increased his holdings of common stock.

Summary

• William P. Forbes, an executive at Heron Therapeutics, exercised 3,874 restricted stock units on January 19, 2025.
• These units converted into 3,874 shares of common stock.
• Following this transaction, Forbes directly owns 106,997 shares of common stock and 46,492 restricted stock units.
• The restricted stock units vest in 16 equal quarterly installments starting one quarter after the grant date of January 19, 2024.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction, not indicative of any major positive or negative sentiment. It's a standard executive stock option exercise.

Positives

• The exercise of stock options by an executive can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when executives exercise stock options or make other changes in their beneficial ownership of company stock. It is a routine part of corporate governance and transparency.

Comparison to Industry Standards

• Stock option exercises are a common form of executive compensation in publicly traded companies, particularly in the biotechnology and pharmaceutical sectors.
• The vesting schedule of 16 equal quarterly installments is a typical structure for restricted stock units.
• The reporting of these transactions via SEC Form 4 is a standard practice to ensure transparency and prevent insider trading.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates executive confidence in the company.

Key Dates

Keywords

stock options, restricted stock units, insider trading, executive compensation, Heron Therapeutics, HRTX, common stock